Alta Newport Hospital, LLC
Alta Newport Hospital, LLC was paid $1.16M by Medicaid between Jan 2018 and Nov 2024, across 86 billing codes. Its largest line is 0450, Emergency room services — 12% of everything it billed.
TUSTIN, CA 92780
Next to other General Acute Care Hospital providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,911 | $49K | |
| 2019 | 16,942 | $153K | |
| 2020 | 18,302 | $121K | |
| 2021 | 24,991 | $138K | |
| 2022 | 25,373 | $196K | |
| 2023 | 22,505 | $266K | |
| 2024incomplete | 11,027 | $233K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 12% | 9,880 | 8,273 | $133K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 9.2% | 2,868 | 1,602 | $106K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 8.6% | 4,696 | 3,464 | $99K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 7.0% | 2,325 | 1,745 | $81K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.8% | 2,460 | 1,963 | $79K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 5.5% | 833 | 680 | $64K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.7% | 3,375 | 2,700 | $43K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.1% | 4,429 | 3,529 | $36K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.8% | 681 | 589 | $32K |
| 0360 | 2.6% | 3,331 | 2,234 | $29K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.4% | 1,265 | 986 | $28K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.4% | 1,928 | 1,560 | $27K |
74 more codes
| 99199 | Unlisted special service, procedure or report | 2.3% | 438 | $27K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.2% | 7,577 | $25K |
| 80053 | Comprehensive metabolic panel | 2.1% | 5,225 | $25K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.0% | 1,568 | $23K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.9% | 796 | $22K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.7% | 536 | $20K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.7% | 742 | $19K |
| 71045 | Radiologic examination, chest; single view | 1.5% | 2,714 | $17K |
| J3490 | Unclassified drugs | 1.5% | 5,560 | $17K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1.4% | 3,784 | $16K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 1.2% | 1,229 | $14K |
| J2704 | Injection, propofol, 10 mg | 1.1% | 5,021 | $12K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.0% | 1,714 | $12K |
| 99283 | Emergency room visit (moderate) | <1% | 1,190 | $11K |
| 84484 | <1% | 2,166 | $10K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,458 | $9K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,005 | $9K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 703 | $8K |
| 83690 | <1% | 2,531 | $8K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 287 | $8K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,208 | $7K |
| 85730 | <1% | 2,526 | $6K | |
| 83880 | <1% | 352 | $6K | |
| 81025 | <1% | 3,088 | $6K | |
| 0710 | <1% | 2,958 | $5K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 149 | $5K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,629 | $5K |
| 85610 | <1% | 2,631 | $4K | |
| 81001 | <1% | 3,288 | $4K | |
| 0270 | <1% | 3,758 | $4K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 764 | $3K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 473 | $2K |
| 87088 | <1% | 680 | $2K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,360 | $2K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 469 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 428 | $2K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 449 | $2K |
| 81003 | <1% | 2,730 | $2K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 511 | $2K |
| 82150 | <1% | 663 | $2K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 626 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,200 | $1K |
| 86328 | <1% | 77 | $1K | |
| 82550 | <1% | 298 | $962.11 | |
| Z7502 | <1% | 25 | $899.00 | |
| 83605 | <1% | 137 | $886.65 | |
| 87040 | <1% | 154 | $694.33 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 157 | $674.85 |
| 90715 | <1% | 20 | $664.02 | |
| 83735 | <1% | 264 | $593.64 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 125 | $484.03 |
| 82948 | <1% | 290 | $370.10 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 28 | $322.14 |
| 94644 | <1% | 16 | $227.62 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 46 | $191.92 |
| 87338 | <1% | 25 | $166.26 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 31 | $146.26 |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 43 | $103.68 |
| 0250 | <1% | 276 | $56.93 | |
| 85378 | <1% | 13 | $28.34 | |
| 88312 | <1% | 16 | $25.06 | |
| 0307 | 0% | 45 | $0.00 | |
| 0258 | 0% | 52 | $0.00 | |
| 0324 | 0% | 18 | $0.00 | |
| 0306 | 0% | 126 | $0.00 | |
| 0636 | 0% | 77 | $0.00 | |
| 99241 | 0% | 30 | $0.00 | |
| 0305 | 0% | 91 | $0.00 | |
| 0301 | 0% | 120 | $0.00 | |
| G9656 | Patient transferred directly from anesthetizing location to pacu or other non-icu location | 0% | 1,561 | $0.00 |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 1,583 | $0.00 |
| 0320 | 0% | 15 | $0.00 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 0% | 24 | $0.00 |
| 0300 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.